Siemens Healthineers redefines the biopsy workflow in mammography with the new Mammomat Revelation.
The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Further details are available from the local Siemens Healthineers organizations.
Mammomat Revelation's current FDA approval status is currently "510k pending".